Markets:

Overview

News

Currencies

International

Treasuries

Solventum Corporation Common Stock (NY:SOLV)

80.67 +0.62 (+0.77%)

Streaming Delayed Price Updated: 11:00 AM EST, Jan 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >

1 Value Stock for Long-Term Investors and 2 to Approach with Caution

July 11, 2025

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...

Via StockStory

3 Mid-Cap Stocks with Questionable Fundamentals

June 20, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

3 Low-Volatility Stocks Facing Headwinds

June 17, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

SOLVENTUM CORP (NYSE:SOLV) - A Strong Technical Setup for Breakout Investors ↗

June 14, 2025

SOLVENTUM CORP (NYSE:SOLV) shows strong technicals and a high-quality setup, making it a breakout candidate for traders. The stock has outperformed 83% of the market and presents clear support levels.

Via Chartmill

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum

June 10, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 2.7% year on year to $2.07 billion. Its non-GAAP profit of...

Via StockStory

Topics Economy World Trade

Q1 Rundown: Solventum (NYSE:SOLV) Vs Other Surgical Equipment & Consumables - Diversified Stocks

June 04, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Solventum (NYSE:SOLV) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

3 Healthcare Stocks Skating on Thin Ice

June 02, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

2 Profitable Stocks Worth Investigating and 1 to Be Wary Of

May 26, 2025

A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Firing on All Cylinders: CONMED (NYSE:CNMD) Q1 Earnings Lead the Way

May 19, 2025

Looking back on surgical equipment & consumables - diversified stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

Assessing Solventum: Insights From 9 Financial Analysts ↗

May 19, 2025

Via Benzinga

What's going on in today's session: S&P500 movers ↗

May 14, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Which S&P500 stocks are gapping on Wednesday? ↗

May 14, 2025

Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.

Via Chartmill

3 of Wall Street’s Favorite Stocks Walking a Fine Line

May 13, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Topics Economy

Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know

May 12, 2025

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides...

Via StockStory

Topics Government Stocks World Trade

Stay informed with the top movers within the S&P500 index on Friday. ↗

May 09, 2025

Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

May 09, 2025

Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Solventum (NYSE:SOLV) Exceeds Q1 Expectations

May 08, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) announced better-than-expected revenue in Q1 CY2025, with sales up 2.7% year on year to $2.07 billion. Its non-GAAP profit of $1.34 per share was...

Via StockStory

Solventum Earnings: What To Look For From SOLV

May 07, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting earnings tomorrow after market close. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

7 Analysts Assess Solventum: What You Need To Know ↗

April 30, 2025

Via Benzinga

Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday? ↗

May 07, 2025

U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET.

Via Benzinga

Topics Economy

3 Cash-Producing Stocks Walking a Fine Line

April 27, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Alpha Buying: Big Oil Becomes Ground Zero for Activist Investing in 2025 ↗

April 24, 2025

Via Benzinga

Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty ↗

April 23, 2025

Thermo Fisher topped Q1 estimates with $5.15 EPS and $10.36 billion revenue, boosted by diagnostics and life sciences growth.

Via Benzinga

Which S&P500 stocks have an unusual volume on Thursday? ↗

April 03, 2025

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.

Via Chartmill

Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)

March 28, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS...

Via StockStory

Topics Artificial Intelligence Economy

Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)

March 24, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and...

Via StockStory

Topics Artificial Intelligence Economy

3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy ↗

March 21, 2025

Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS.

Via Benzinga

Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

March 21, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared...

Via StockStory

Topics Artificial Intelligence Economy

Solventum (SOLV): Buy, Sell, or Hold Post Q4 Earnings?

March 18, 2025

Solventum has been treading water for the past six months, recording a small return of 2.6% while holding steady at $74.01.

Via StockStory

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Contact Us

Contact Us

Solventum Corporation Common Stock (NY:SOLV)

All News about Solventum Corporation Common Stock